Here’s a structured collection of FAQs tailored for researchers working with VPS15 antibody in academic settings, incorporating methodological insights and data from peer-reviewed studies:
Co-IP protocols:
Treat cells with proteasome inhibitors (MG132) or lysosomal inhibitors (chloroquine) during CHX chase experiments .
Perform Nedd4 knockdown to reduce K11-linked polyubiquitination of VPS15 .
Use automated image analysis (e.g., CellProfiler) to quantify LC3/VPS15 vesicle colocalization .
For PI3P quantification: Employ 2xFYVE-GFP reporters and measure fluorescence intensity after wortmannin treatment .
If Lamp2/VPS15 colocalization is inconsistent: